Original version

BBC World Service

BBC World Service Radio

World Service Radio

Health Check

Factual: Health & Wellbeing

Factual: Science & Nature: Science & Technology

Health issues and medical breakthroughs from around the world.

BBC World Service schedule for American satellite radio and the Caribbean

BBC World Service Americas and the Caribbean

BBC World Service Europe and the Middle East

BBC World Service Online

BBC World Service Australasia

BBC World Service South Asia

BBC World Service East Asia

BBC World Service East and Southern Africa Schedule

BBC World Service East and Southern Africa

BBC World Service West and Central Africa Schedule

BBC World Service West and Central Africa

Health Check: British Trial Hope for Leukaemia Patients

Magazines & Reviews

British Trial Hope for Leukaemia Patients

2018/03/14 GMT

BBC World Service - Health Check, British Trial Hope for Leukaemia Patients

British medical trial offers hope to leukaemia patients

New drugs offer hope for commonest form of leukaemia

Could a British medical trial herald a cure for the commonest type of blood cancer?  BBC reporter Simon Cox has had Chronic Lymphocytic Leukaemia or CLL for more than a decade.  Like him, many patients don’t have health problems for years.  For those who do need treatment, options include chemotherapy or bone marrow transplants.  

CLL is a disease of the immune system – the lymphocyte cells which fight infections and then die, instead grow out of control and can’t be “switched off”.   

Simon Cox talks to Peter Hillmen, professor of experimental haematology at St James’ hospital in Leeds in northern England who’s on a mission to find a cure.  He’s recruited 50 CLL patients – whose disease returned after chemotherapy - onto the Clarity trial.  They are given two non-chemotherapy drugs - Venetoclax and Ibrutinib – to target elements of CLL - the proliferation of cells and their inability to die off. 

Andy Wright is on the trial. Initially 84% of his bone marrow cells contained CLL. After eight months that figure had fallen to just 0.0085%.  

A third of the trial patients have no trace of CLL – an unprecedented response which Professor Hillmen believes means a cure is now much closer. 



(Photo:  Simon Cox with Andy Wright, one of the patients on the Clarity trial © BBC)

Accessibility links

Programme Index

Health Check

British Trial Hope for Leukaemia Patients

Genres

Formats

Brand

BBC World Service

About BBC World Service